Drugmakers’ failed attempts to reduce promotional outlays

Published: 2012-03-21 06:59:00

Updated: 2012-03-21 06:59:00

Local pharmaceutical companies have been making all-outs to cut their promotional expenditures as part of efforts to brace for effects of gov’t-imposed price cuts, but with no available.

According to a report recently released by Yakup.com, the country's 35 KOSPI-listed drug firms on average s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK